Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 6 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

4(66.7%)

Phase 2

2(33.3%)

6Total

N/A(4)

Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT06145308Phase 2Recruiting

Precision Treatment of Recurrent/Metastatic Salivary Gland Carcinoma Guided by Molecular Typing

Role: collaborator

NCT06378255Not ApplicableCompleted

Clinical Evaluation of Polycation-based New Dental Desensitizer on Dentin Hypersensitivity

Role: lead

NCT07339371Not Yet Recruiting

Comprehensive Care of Sleep Disordered Breathing

Role: collaborator

NCT07197437Not ApplicableCompleted

Efficacy of Universal Bonding Agents as Desensitizers

Role: lead

NCT06009861Phase 2Active Not Recruiting

Neoadjuvant Tislelizumab Plus Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer (NeoSPOT)

Role: lead

NCT02395367Completed

Prospective, Observational, Real-world Oral Malignant Tumors Study

Role: collaborator

NCT05218590Not ApplicableCompleted

For Nasotracheal Intubation With Video Rigid Stylet, Which Nostril is Better?

Role: collaborator

NCT04454866Not ApplicableCompleted

Penehyclidine for Prevention of Nausea and Vomiting After Bimaxillary Surgery

Role: collaborator

NCT04112771Completed

Penehyclidine and Postoperative Nausea and Vomiting After Bimaxillary Surgery

Role: collaborator

All 9 trials loaded